tainted heparin Tagged Articles

FDA notifies public about changes to heparin potency

Posted: October 7, 2009 Pharmaceutical

The blood thinner heparin will now include a new reference standard and test method that is used to determine the potency of the drug and detect impurities that may be present in it, according to a safety alert issued by

Watchdog group pressures FDA about contaminated syringes

Posted: June 10, 2009 Pharmaceutical

Watchdog group Project on Government Oversight (POGO) is asking the Food and Drug Administration (FDA) inspector general to investigate why the agency failed to stop contaminated syringes from reaching the public that caused four deaths and 162 serious injuries to

Baxter says it's not responsible for recent heparin deaths, illness

Posted: May 18, 2009 Pharmaceutical

It’s like a bad dream happening all over again – people falling ill or dying after receiving doses of the blood thinner heparin. In 2007, tainted doses of heparin killed more than 80 Americans and injured hundreds more. And while

Obama's pick for FDA commissioner wants to restore trust in agency

Posted: May 9, 2009 Pharmaceutical

President Barack Obama’s top pick for Food and Drug Administration (FDA) commissioner, Bioterrorsim expert and former New York City health commissioner Dr. Margaret Hamburg, says that she wants to restore public confidence in the FDA, according to Boston.com. She already

Congressman demands answers on tainted heparin scandal

Posted: May 6, 2009 Pharmaceutical

Rep. Joe Barton of Texas wants the Food and Drug Administration (FDA) to turn over databases stemming from last year’s tainted heparin scandal that killed more than 80 Americans and injured hundreds more, according to NASDAQ.com. At a public hearing

FDA panel recommends agency approval of heparin alternative

Posted: March 23, 2009 Pharmaceutical

A Food and Drug Administration (FDA) advisory panel voted last week to recommend agency approval of experimental blood thinner rivaroxaban, according to Forbes. The medication, made by Johnson & Johnson and Bayer Healthcare Pharmaceuticals, is designed to be used on

Hamburg, Sharfstein to head troubled FDA

Posted: March 13, 2009 Pharmaceutical

The Obama administration has named two doctors to head up the much-criticized U.S. Food and Drug Administration (FDA), individuals who are known for speaking out about public safety. Sources say Margaret Hamburg, a physician and former New York City health

Class action lawsuit filed against Baxter over tainted heparin scandal

Posted: March 4, 2009 Pharmaceutical

A class action lawsuit has been filed against Baxter claiming the drug maker substituted an ingredient in its blood thinner heparin with a cheaper, more dangerous one in order to reap more profits, according to the Madison-St. Clair The Record.

New budget supports plan for importation of drugs

Posted: February 27, 2009 Pharmaceutical

As a presidential candidate, President Barack Obama said he supported individuals’ rights to import cheaper drugs from other countries provided the FDA beefed up its inspections to ensure the imports are safe. His new budget plan backs up that claim,

FDA knew of tainted syringes two years before inspecting plant

Posted: February 26, 2009 Pharmaceutical

The FDA received reports of about debris in syringes filled with heparin and saline distributed by AM2PAT as early as 2005, yet the agency didn’t follow up on those complaints until 2007, after five deaths and hundreds of illnesses were